Investing in a Healthy Future

We develop innovative healthcare and technology companies focused on improving quality of life, successfully transitioning from research to commercial opportunity.

Subscribe to the VIC newsletter

OUR Approach

We Bring World Changing
Technologies to Global Markets

VIC's novel business model manages risks, provides
higher upsides, and lowers capital burn rates.

PORTFOLIO DEVELOPMENT

Maximize The Opportunity
For Startup Success

An important element of VIC's business model is that it enables the technical team in each newly formed startup to focus tightly on product development, while VIC's seasoned business development team manages the demands of financing and growing the business.

FEATURED RESOURCES

NEWS
VIC Technology Venture Development Forms New Portfolio Company: Neurexis Therapeutics
CASE STUDY
The Emerging Remote Workplace: Digital Best Practices for Investor Groups
REPORTS
VIC 2019 Annual Report
White Paper
New Paradigms of Life Science Investing
NEWS
VIC Portfolio Companies and Pipeline Technologies with Pandemic Impact
INTERVIEW
Behind the Curtain with Biolocity | Guiding Medical Innovations to Market
White Paper
Accessing Innovation Directly from the Source - Growing Trends in Venture Capital Company Formation
CASE STUDY
Behind the Curtain: Opportunity Assessment at VIC Technology Venture Development
NEWS
VIC Technology Venture Development Forms New Portfolio Company: Filtravate
INTERVIEW
An Interview with Nichole Mercier at Washington University
FROM THE CORNER OFFICE
SFC Fluidics Nears FDA Submission

PORTFOLIO

Our Portfolio Companies

VIC portfolio companies are bringing innovations from the lab to the market to create a better future.

JOIN US

Companies built from the ground up based on high impact technologies exclusively licensed from top research institutions around the world.

Each newly created VIC portfolio company receives a $250k to $500k seed investment from the VIC Investor Network (VIN).

ACCREDITED INVESTORS

Contact VIC for investment opportunities in companies with world-class technologies and management teams. Advantages include accessing a unique asset class, highly vetted opportunities, risk diversification, and investor protections.

TECHNOLOGY LICENSING MANAGERS

Contact VIC to see how we can help you realize the commercial value of your technologies with a higher success rate and a faster time to market. We assemble world-class teams, provide formational capital, and build the companies for success from the ground up.

SUBJECT MATTER EXPERTS

Experts in medical devices, diagnostics, therapeutics, and emerging technology areas such as analytical instrumentation, advanced materials, and cleantech: Contact VIC to see how you can be involved with a rapidly growing pipeline of new opportunities.

Get Started

At VIC, we develop companies based on transformative technologies. These technologies help create a sustainable, healthy future for people around the world. Please contact us to learn about joining the VIC Technology Portfolio.